These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7645561)

  • 21. Sneddon's syndrome: MR imaging findings.
    Karagülle AT; Karadağ D; Erden A; Erden I
    Eur Radiol; 2002 Jan; 12(1):144-6. PubMed ID: 11868091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of Sneddon's syndrome associated with Moskowitz's syndrome].
    Belfeki N; Dieudonné L
    Rev Med Liege; 2015 Nov; 70(11):546-9. PubMed ID: 26738265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, neurovascular and neuropathological features in Sneddon's syndrome.
    Marinho JL; Piovesan EJ; Leite Neto MP; Kotze LR; Noronha Ld; Twardowschy CA; Lange MC; Scola RH; Zétola VH; Nóvak EM; Werneck LC
    Arq Neuropsiquiatr; 2007 Jun; 65(2B):390-5. PubMed ID: 17665002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.
    Martínez-Valle F; Ordi-Ros J; Selva-O'Callaghan A; Balada E; Solans-Laque R; Vilardell-Tarres M
    Med Clin (Barc); 2009 May; 132(20):767-71. PubMed ID: 19403146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sneddon's syndrome (livedo reticularis and cerebrovascular lesions) with antiphospholipid antibodies and severe dementia in young man: a case report.
    Jura E; Palasik W; Meurer M; Palester-Chlebowczyk M; Czlonkowska A
    Acta Neurol Scand; 1994 Feb; 89(2):143-6. PubMed ID: 8191878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sneddon's syndrome: a vascular systemic disease with kidney involvement?
    Macário F; Macário MC; Ferro A; Gonçalves F; Campos M; Marques A
    Nephron; 1997; 75(1):94-7. PubMed ID: 9031277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of Sneddon's syndrome with positive ANA and anti-cardiolipin antibodies: primary anti-phospholipid syndrome?
    Otoyama K; Katayama I; Suzuki Y; Tone T; Nishioka K; Nishiyama S
    J Dermatol; 1990 Aug; 17(8):489-92. PubMed ID: 2229653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sneddon's syndrome.
    Stephens CJ
    Clin Exp Rheumatol; 1992; 10(5):489-92. PubMed ID: 1458702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein Z deficiency in antiphospholipid-negative Sneddon's syndrome.
    Ayoub N; Esposito G; Barete S; Soria C; Piette JC; Francès C
    Stroke; 2004 Jun; 35(6):1329-32. PubMed ID: 15105516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.
    Kraemer M; Linden D; Berlit P
    J Neurol; 2005 Oct; 252(10):1155-66. PubMed ID: 16133722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sneddon's syndrome--clinical course and out-come.
    O'Riordan JI; Javed M; Murphy R; Hutchinson M
    Ir Med J; 1995; 88(2):66-7. PubMed ID: 7775150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of Sneddon's syndrome.
    Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D
    Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sneddon's syndrome: a systemic arterio-occlusive disorder.
    al Meshari K; al Eisa A; Akhtar M
    Am J Kidney Dis; 1995 Aug; 26(2):368-72. PubMed ID: 7645543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sneddon's syndrome in a young woman with antiphospholipid syndrome, ischaemic apoplexy and epileptic seizures].
    Stenør C; Sørensen MT
    Ugeskr Laeger; 2019 May; 181(19):. PubMed ID: 31120013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Livedo racemosa: a report of five cases.
    Zala L; Braathen LR
    Dermatology; 1994; 189(4):421-4. PubMed ID: 7873835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sneddon's syndrome and antithrombin III.
    Bolayir E; Keçeci H; Akyol M; Taş A; Polat M
    J Dermatol; 1999 Aug; 26(8):532-4. PubMed ID: 10487010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.